This Is Why Rapid Dose Therapeutics Corp.'s (CSE:DOSE) CEO Compensation Looks Appropriate
Aug 22
Have your own idea? Try our Stock Screener
Markets has moved to Discover
You can now access Markets by navigating to Discover and selecting Markets.
Canadian (TSX) Life Sciences Industry Analysis
UpdatedAug 31, 2024
DataAggregated Company Financials
Companies3
- 7D-5.3%
- 3M-7.9%
- 1Y62.2%
- YTD42.9%
Over the last 7 days, the Life Sciences industry has remained flat, although notably Rapid Dose Therapeutics gained 11%. As for the the longer term, the industry is up 69% over the past 12 months.
Industry Valuation and Performance
Has the Canadian Life Sciences Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sat, 31 Aug 2024 | CA$61.8m | CA$5.1m | -CA$4,554,454.00 | n/a | -13.6x | 12.1x |
| Mon, 29 Jul 2024 | CA$59.3m | CA$5.1m | -CA$4,366,737.00 | n/a | -13.6x | 11.5x |
| Wed, 26 Jun 2024 | CA$55.0m | CA$4.9m | -CA$3,824,483.00 | n/a | -14.4x | 11.2x |
| Fri, 24 May 2024 | CA$55.1m | CA$4.9m | -CA$3,824,483.00 | n/a | -14.4x | 11.2x |
| Sun, 21 Apr 2024 | CA$61.7m | CA$4.8m | -CA$3,858,765.00 | n/a | -16x | 12.9x |
| Tue, 19 Mar 2024 | CA$66.9m | CA$4.9m | -CA$2,943,594.00 | n/a | -22.7x | 13.6x |
| Thu, 15 Feb 2024 | CA$50.3m | CA$4.9m | -CA$1,290,813.00 | n/a | -38.9x | 10.2x |
| Sat, 13 Jan 2024 | CA$206.6m | CA$23.4m | -CA$24,636,048.00 | n/a | -8.4x | 8.8x |
| Mon, 11 Dec 2023 | CA$194.5m | CA$23.5m | -CA$24,854,730.00 | n/a | -7.8x | 8.3x |
| Wed, 08 Nov 2023 | CA$193.5m | CA$23.7m | -CA$24,695,492.00 | n/a | -7.8x | 8.2x |
| Fri, 06 Oct 2023 | CA$196.0m | CA$23.7m | -CA$24,695,492.00 | n/a | -7.9x | 8.3x |
| Sun, 03 Sep 2023 | CA$197.7m | CA$23.7m | -CA$24,644,997.00 | n/a | -8x | 8.4x |
| Tue, 01 Aug 2023 | CA$202.2m | CA$23.5m | -CA$24,780,404.00 | n/a | -8.2x | 8.6x |
| Thu, 29 Jun 2023 | CA$175.6m | CA$22.5m | -CA$25,042,100.00 | n/a | -7x | 7.8x |
| Sat, 27 May 2023 | CA$174.7m | CA$22.5m | -CA$25,042,100.00 | n/a | -7x | 7.8x |
| Mon, 24 Apr 2023 | CA$186.7m | CA$23.0m | -CA$29,977,765.00 | 40.3x | -6.2x | 8.1x |
| Wed, 22 Mar 2023 | CA$189.4m | CA$23.0m | -CA$29,977,765.00 | 35.1x | -6.3x | 8.3x |
| Fri, 17 Feb 2023 | CA$196.2m | CA$23.0m | -CA$29,977,765.00 | 57.2x | -6.5x | 8.5x |
| Sun, 15 Jan 2023 | CA$193.1m | CA$22.4m | -CA$30,499,829.00 | 36.4x | -6.3x | 8.6x |
| Tue, 13 Dec 2022 | CA$191.6m | CA$21.8m | -CA$30,309,915.00 | 44.2x | -6.3x | 8.8x |
| Thu, 10 Nov 2022 | CA$198.0m | CA$21.7m | -CA$30,373,079.00 | 63.1x | -6.5x | 9.1x |
| Sat, 08 Oct 2022 | CA$189.5m | CA$21.7m | -CA$30,373,079.00 | 87.8x | -6.2x | 8.7x |
| Mon, 05 Sep 2022 | CA$202.0m | CA$21.6m | -CA$24,222,079.00 | 78.8x | -8.3x | 9.3x |
| Wed, 03 Aug 2022 | CA$165.8m | CA$21.9m | -CA$23,995,882.00 | 20.5x | -6.9x | 7.6x |
| Fri, 01 Jul 2022 | CA$154.3m | CA$21.5m | -CA$26,689,749.00 | 20.5x | -5.8x | 7.2x |
| Sun, 29 May 2022 | CA$203.9m | CA$21.5m | -CA$26,689,749.00 | 18.7x | -7.6x | 9.5x |
| Tue, 26 Apr 2022 | CA$239.2m | CA$21.6m | -CA$23,635,914.00 | 25.9x | -10.1x | 11.1x |
| Thu, 24 Mar 2022 | CA$161.7m | CA$21.6m | -CA$23,635,914.00 | 25.9x | -6.8x | 7.5x |
| Sat, 19 Feb 2022 | CA$198.8m | CA$21.3m | -CA$21,103,914.00 | 27.3x | -9.4x | 9.3x |
| Mon, 17 Jan 2022 | CA$251.4m | CA$20.9m | -CA$20,076,847.00 | 30x | -12.5x | 12x |
| Wed, 15 Dec 2021 | CA$241.9m | CA$20.9m | -CA$19,542,526.00 | 25.9x | -12.4x | 11.6x |
| Fri, 12 Nov 2021 | CA$257.7m | CA$21.0m | -CA$14,997,109.00 | 24.6x | -17.2x | 12.3x |
| Sun, 10 Oct 2021 | CA$249.3m | CA$20.7m | -CA$14,899,797.00 | 25.2x | -16.7x | 12.1x |
| Tue, 07 Sep 2021 | CA$249.7m | CA$20.7m | -CA$11,409,216.00 | 20.4x | -21.9x | 12.1x |
Price to Earnings Ratio
-21.9x
Current Industry PE
- There are only 3 companies in the Canadian Life Sciences industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.
Past Earnings Growth
- The earnings for companies in the Life Sciences industry have improved over the last three years.
- Meanwhile revenues for these companies have declined 37% per year.
- This means that less sales are being generated overall, but since the cost of doing business is lower, losses have been shrinking.
Industry Trends
Which industries have driven the changes within the Canadian Healthcare industry?
| CA Market | 0.28% | |
| Healthcare | -5.49% | |
| Life Sciences | -5.26% | |
| Clinical Research and Equipment | -5.26% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| DOSE Rapid Dose Therapeutics | CA$0.15 | 10.7% +CA$1.9m | 10.7% | PS16.4x |